Evoke Pharma, Inc.
Hedge Funds Holdings
Last updated:
Evoke Pharma, Inc.‘s stocks are currently a part of 8 hedge funds’ portfolios, which represents 0.58% of the total amount of its stocks outstanding. This makes up a total of 18.16K shares of Evoke Pharma, Inc.. Compared to the previous quarter, the number fell by -70.15% or -42.67K shares fewer. As for the holding position changes, 12.5% (1) of current hedge fund investors increased the number of shares held, 12.5% (1) of current holders sold a part of the shares held. 2 hedge funds are new holders of Evoke Pharma, Inc. stock in Q1 2023, it is 25% of total holders.
Hedge funds holding Evoke Pharma (Q2 2018 – Q1 2023)
| Q2 2018 | 20 |
|---|---|
| Q3 2018 | 21 |
| Q4 2018 | 19 |
| Q1 2019 | 22 |
| Q2 2019 | 17 |
| Q3 2019 | 17 |
| Q4 2019 | 16 |
| Q1 2020 | 16 |
| Q2 2020 | 18 |
| Q3 2020 | 25 |
| Q4 2020 | 30 |
| Q1 2021 | 24 |
| Q2 2021 | 18 |
| Q3 2021 | 20 |
| Q4 2021 | 20 |
| Q1 2022 | 17 |
| Q2 2022 | 7 |
| Q3 2022 | 6 |
| Q4 2022 | 10 |
| Q1 2023 | 8 |
Hedge funds changes in Evoke Pharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 3 | 4 | 1 | 3 | 9 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 4 | 2 | 2 | 10 |
| Q4 2018 | 3 | 3 | 1 | 5 | 7 |
| Q1 2019 | 6 | 2 | 4 | 3 | 7 |
| Q2 2019 | 4 | 2 | 3 | 9 | -1 |
| Q3 2019 | 5 | 3 | 2 | 5 | 2 |
| Q4 2019 | 3 | 3 | 1 | 4 | 5 |
| Q1 2020 | 2 | 3 | 1 | 1 | 9 |
| Q2 2020 | 5 | 5 | 1 | 4 | 3 |
| Q3 2020 | 10 | 3 | 4 | 3 | 5 |
| Q4 2020 | 7 | 9 | 5 | 3 | 6 |
| Q1 2021 | 5 | 5 | 3 | 11 | 0 |
| Q2 2021 | 3 | 5 | 3 | 9 | -2 |
| Q3 2021 | 3 | 5 | 4 | 1 | 7 |
| Q4 2021 | 4 | 4 | 4 | 4 | 4 |
| Q1 2022 | 2 | 5 | 5 | 5 | 0 |
| Q2 2022 | 7 | 0 | 0 | 17 | -17 |
| Q3 2022 | 0 | 0 | 5 | 1 | 0 |
| Q4 2022 | 5 | 0 | 2 | 1 | 2 |
| Q1 2023 | 2 | 1 | 1 | 0 | 4 |
Hedge funds changes in Evoke Pharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 1,357,000 | 825,000 |
| Q4 2020 | 703,000 | 381,000 |
| Q1 2021 | 1,539,000 | 155,000 |
| Q2 2021 | 745,000 | 19,000 |
| Q3 2021 | 329,000 | 4,000 |
| Q4 2021 | 29,000 | 2,000 |
| Q1 2022 | 0 | 1,000 |
| Q2 2022 | 39,000 | 17,000 |
| Q3 2022 | 12,000 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of Evoke Pharma, Inc. (NASDAQ:EVOK)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| VANGUARD GROUP INC | 56K | 29.85K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 39K | 20.89K | 0.000% |
| BLACKROCK INC. Larry Fink | 15K | 7.97K | 0.000% |
| GROUP ONE TRADING, L.P. | 12K | 6.3K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 4K | 2.24K | 0.000% |
| UBS GROUP AG | 2K | 1.10K | 0.000% |
| GROUP ONE TRADING, L.P. | 1K | 338 | 0.000% |
| GROUP ONE TRADING, L.P. | 0 | 0 | 0.000% |
| CITIGROUP INC | 0 | 0 | 0.000% |